PTPRD was also shown to be involved in colon cancer cell migration via a β-catenin/TCF/CD44 signalling pathway, whereas in lung cancer PTPRD appears to act as a tumour suppressor gene [18,19,20]. The gene discussed is CD44; the disease is lung carcinoma.